Roche

Showing 15 posts of 710 posts found.

Avastin helps Roche outpace the market again

April 16, 2009
Sales and Marketing Roche

Strong sales growth across all its business divisions, including prescription medicines has helped Roche outpace the market again in the …

Roche lines up manufacturing and R&D reshuffle

April 1, 2009
Sales and Marketing Genentech, Roche

Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …

Roche buys out Genentech with increased bid

March 12, 2009
Sales and Marketing MA, Roche

Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …

Genentech urges shareholders to reject Roche bid

February 24, 2009
Sales and Marketing Genentech, Roche

The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …

Roche rejoins ABPI after six-month suspension

February 23, 2009
Sales and Marketing Code of Practice, Roche

Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …

Positive results halt Avastin-Tarceva trial

February 16, 2009
Sales and Marketing Cancer, Roche, avastin

A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …

Roche hit by strong Swiss franc

February 10, 2009
Sales and Marketing Roche

Roche delivered solid performance in 2008, but was unable to shake off the negative effect of a strong Swiss franc. …

Roche bid for Genentech turns ‘hostile’ – but stays friendly

February 10, 2009
Sales and Marketing MA, Roche

Roche has launched a renewed bid to buy out Genentech, making a 'hostile' bid for the company by appealing directly …

RoActemra approved in Europe

January 29, 2009
Sales and Marketing RoActemra, Roche

The European Commission has approved Roche's RoActemra as a treatment for rheumatoid arthritis. Schering-Plough's Remicade, Wyeth's Enbrel and Abbott's Humira …

Roche to cut 780 production jobs

January 21, 2009
Manufacturing and Production Roche, restructure

Roche will shed 780 production jobs over the next two years as it continues to streamline its manufacturing operations, but …

Roche celebrates 100 years in the UK

January 21, 2009
Sales and Marketing Roche

Roche has marked the centenary of the opening of its UK office by raising £20,000 for a local charity. To …

New Pegasys licence gives patients ‘second chance for a cure’

December 4, 2008
Sales and Marketing Roche, hepatitis

Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …

Roche’s RoActemra recommended for approval

November 26, 2008
Sales and Marketing RA, Roche

European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …

Roche strikes deal over Tarceva price

November 17, 2008
Sales and Marketing Roche, Taxotere

NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …

The Gateway to Local Adoption Series

Latest content